- Home
- BGLC vs EMKR Comparison
BGLC vs EMKR Comparison
Compare BGLC & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- EMKR
- Stock Information
- Founded
- BGLC 2017
- EMKR 1984
- Country
- BGLC Malaysia
- EMKR United States
- Employees
- BGLC N/A
- EMKR N/A
- Industry
- BGLC Medical Specialities
- EMKR Semiconductors
- Sector
- BGLC Health Care
- EMKR Technology
- Exchange
- BGLC Nasdaq
- EMKR Nasdaq
- Market Cap
- BGLC 7.6M
- EMKR 9.5M
- IPO Year
- BGLC N/A
- EMKR 1997
- Fundamental
- Price
- BGLC $0.37
- EMKR $2.33
- Analyst Decision
- BGLC
- EMKR Buy
- Analyst Count
- BGLC 0
- EMKR 2
- Target Price
- BGLC N/A
- EMKR $3.00
- AVG Volume (30 Days)
- BGLC 117.9K
- EMKR 2.0M
- Earning Date
- BGLC 11-20-2024
- EMKR 12-10-2024
- Dividend Yield
- BGLC N/A
- EMKR N/A
- EPS Growth
- BGLC N/A
- EMKR N/A
- EPS
- BGLC N/A
- EMKR N/A
- Revenue
- BGLC $9,183,168.00
- EMKR $90,961,000.00
- Revenue This Year
- BGLC N/A
- EMKR N/A
- Revenue Next Year
- BGLC N/A
- EMKR $7.07
- P/E Ratio
- BGLC N/A
- EMKR N/A
- Revenue Growth
- BGLC N/A
- EMKR 413.79
- 52 Week Low
- BGLC $0.31
- EMKR $0.78
- 52 Week High
- BGLC $3.39
- EMKR $7.20
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- EMKR 67.47
- Support Level
- BGLC $0.38
- EMKR $2.07
- Resistance Level
- BGLC $0.49
- EMKR $2.54
- Average True Range (ATR)
- BGLC 0.02
- EMKR 0.16
- MACD
- BGLC -0.01
- EMKR -0.02
- Stochastic Oscillator
- BGLC 5.94
- EMKR 55.32
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.